BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31568647)

  • 21. Extragonadal malignant germ cell tumors: a clinicopathological and immunohistochemical analysis of 48 cases at a single Chinese institution.
    Gao Y; Jiang J; Liu Q
    Int J Clin Exp Pathol; 2015; 8(5):5650-7. PubMed ID: 26191277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP.
    Talerman A; Haije WG; Baggerman L
    Cancer; 1980 Jul; 46(2):380-5. PubMed ID: 6155988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pitfalls in the interpretation of specimens from patients with testicular tumours, with an emphasis on variant morphologies.
    Ulbright TM
    Pathology; 2018 Jan; 50(1):88-99. PubMed ID: 29129333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual Presentations of Gynecologic Tumors: Extragonadal Yolk Sac Tumor of the Vulva.
    Euscher ED
    Arch Pathol Lab Med; 2017 Feb; 141(2):293-297. PubMed ID: 27959583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in testicular germ cell tumor research.
    van de Geijn GJ; Hersmus R; Looijenga LH
    Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary mediastinal germ cell tumors].
    Couto WJ; Gross JL; Deheinzelin D; Younes RN
    Rev Assoc Med Bras (1992); 2006; 52(3):182-6. PubMed ID: 16847526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor prognosis of retroperitoneal mixed extragonadal germ cell tumors in an HIV-infected man with severe immunosuppression and bilateral cryptorchidism: a case report.
    Li R; Li H
    BMC Cancer; 2019 Mar; 19(1):244. PubMed ID: 30885154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extragonadal germ cell tumors: A clinicopathologic study with emphasis on molecular features, clinical outcomes and associated secondary malignancies.
    Abdulfatah E; Brown NA; Davenport MS; Reichert ZR; Camelo-Piragua S; Heider A; Huang T; Vaishampayan UN; Skala SL; Montgomery JS; Chinnaiyan AM; Kaffenberger SD; Bawa P; Shao L; Mehra R
    Hum Pathol; 2024 Apr; 148():41-50. PubMed ID: 38697270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TCL1 protein expression in testicular germ cell tumors.
    Lau SK; Weiss LM; Chu PG
    Am J Clin Pathol; 2010 May; 133(5):762-6. PubMed ID: 20395523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors.
    Liu A; Cheng L; Du J; Peng Y; Allan RW; Wei L; Li J; Cao D
    Am J Surg Pathol; 2010 May; 34(5):697-706. PubMed ID: 20410807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
    Cheng L; Zhang S; Talerman A; Roth LM
    Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermediate trophoblast in germ cell neoplasms.
    Manivel JC; Niehans G; Wick MR; Dehner LP
    Am J Surg Pathol; 1987 Sep; 11(9):693-701. PubMed ID: 2820253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary intrarenal yolk sac tumor.
    Ragavan N; Kunal PD; Annapurneshwari S
    Indian J Urol; 2017; 33(2):167-168. PubMed ID: 28469308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: an overview.
    Chieffi P; Chieffi S
    J Cell Physiol; 2013 Aug; 228(8):1641-6. PubMed ID: 23359388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
    Cierna Z; Mego M; Miskovska V; Machalekova K; Chovanec M; Svetlovska D; Hainova K; Rejlekova K; Macak D; Spanik S; Ondrus D; Kajo K; Mardiak J; Babal P
    Ann Oncol; 2016 Feb; 27(2):300-5. PubMed ID: 26598537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathology of late recurrence of testicular germ cell tumors.
    Michael H; Lucia J; Foster RS; Ulbright TM
    Am J Surg Pathol; 2000 Feb; 24(2):257-73. PubMed ID: 10680894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in the pathology of germ cell tumors.
    Ulbright TM; Roth LM
    Semin Diagn Pathol; 1987 Nov; 4(4):304-19. PubMed ID: 2832917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonteratomatous germ cell tumors in children.
    Bethel CA; Mutabagani K; Hammond S; Besner GE; Caniano DA; Cooney DR
    J Pediatr Surg; 1998 Jul; 33(7):1122-6; discussion 1126-7. PubMed ID: 9694107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokeratin 7, inhibin, and p63 in testicular germ cell tumor: superior markers of choriocarcinoma compared to β-human chorionic gonadotropin.
    Wegman SJ; Parwani AV; Zynger DL
    Hum Pathol; 2019 Feb; 84():254-261. PubMed ID: 30359635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Anti-Cancer Strategies in Testicular Germ Cell Tumors.
    Chieffi P; De Martino M; Esposito F
    Recent Pat Anticancer Drug Discov; 2019; 14(1):53-59. PubMed ID: 30636617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.